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Abstract
Background: Recent studies showed that progenitor cells could differentiate into mature vascular cells. The main
physiological factors implicated in cell differentiation are specific growth factors. We hypothesized that simply by varying
the oxygen content, progenitor cells can be differentiated either in mature endothelial cells (ECs) or contractile smooth
muscle cells (SMCs) while keeping exactly the same culture medium.
Methodology/Principal Findings: Mononuclear cells were isolated by density gradient were cultivated under hypoxic (5%
O2) or normoxic (21% O2) environment. Differentiated cells characterization was performed by confocal microscopy
examination and flow cytometry analyses. The phenotype stability over a longer time period was also performed. The
morphological examination of the confluent obtained cells after several weeks (between 2 and 4 weeks) showed two
distinct morphologies: cobblestone shape in normoxia and a spindle like shape in hypoxia. The cell characterization showed
that cobblestone cells were positive to ECs markers while spindle like shape cells were positive to contractile SMCs markers.
Moreover, after several further amplification (until 3
rd passage) in hypoxic or normoxic conditions of the previously
differentiated SMC, immunofluorescence studies showed that more than 80% cells continued to express SMCs markers
whatever the cell environmental culture conditions with a higher contractile markers expression compared to control (aorta
SMCs) signature of phenotype stability.
Conclusion/Significance: We demonstrate in this paper that in vitro culture of peripheral blood mononuclear cells with
specific angiogenic growth factors under hypoxic conditions leads to SMCs differentiation into a contractile phenotype,
signature of their physiological state. Moreover after amplification, the differentiated SMC did not reverse and keep their
contractile phenotype after the 3
rd passage performed under hypoxic and normoxic conditions. These aspects are of the
highest importance for tissue engineering strategies. These results highlight also the determinant role of the tissue
environment in the differentiation process of vascular progenitor cells.
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Introduction
During embryogenesis, vasculogenesis is one of the first initiated
processes. Conversely in the adult, the new vessels formation is
initiated from the existent blood vessel ramifications. Data
accumulated in recent years indicate that the circulating
mononuclear cell (MNCs) fractions contain a population of bone
marrow derived cells called progenitor cells that contribute to the
neovascularization of injured vessels. Different authors [1–5]
suggested that these progenitor cells could differentiate in the
presence of different specific cytokines and angiogenic growth
factors (vascular endothelial growth factor (VEGF), platelet
derived growth factor BB (PDGF-BB)…), into mature and
functional endothelial (ECs) or vascular smooth muscle (SMCs)
cells depending on the added specific growth factors. During
wound healing, ischemia, vascular wall remodelling or tumour
development, the formation of new blood vessels is preceded by
the recruitment of MNCs at the injured sites which further
promote vasculogenesis [6–9]. Various authors investigated also
the role of the oxygen concentration on stem cells differentiation
and it was shown that hypoxia increased the production of
angiogenic growth factors such as transforming growth factor b1,
PLoS ONE | www.plosone.org 1 May 2009 | Volume 4 | Issue 5 | e5514PDGF-BB and VEGF [10–12]. The main physiological factors
implicated in cell differentiation are angiogenic growth factors (i.e:
VEGF, bFGF and IGF) [2,3,13] and a decrease of the oxygen level
in the tissue (hypoxia) [5]. Oxygen plays a main role in
physiological and pathological states [14]; it is a potent
biochemical signalling molecule with important regulation prop-
erties for cellular behaviour (migration, differentiation, prolifera-
tion…) [15–17]. However, the possible involvement of hypoxia in
MNCs differentiation into SMCs has never been demonstrated
and even mentioned up to now.
We hypothesized here that the only oxygen concentration
tuning combined with growth factors favouring ECs differentiation
(VEGF, FGF, EGF, IGF) [18] allow the differentiation of
circulating progenitor cells into mature ECs or contractile SMCs,
characteristic of mature vascular cells found in vivo.
We demonstrate that progenitor cells isolated from rabbit
fraction cultivated onto specifically coated solid substrates (either
by type I collagen: a compound of the arterial wall and known as
an ideal substrate for adhesion and proliferation of vascular
smooth muscle cells in vitro [2] or by a Polyelectrolyte
Multilayered Film architecture which previously demonstrated
an important speeding up of endothelial progenitor cells
differentiation into mature and functional endothelial cells [19])
in normoxic conditions (21% O2 atmosphere or 151 mmHg) lead
to mature ECs and to SMCs when cultivated in exactly the same
medium but under moderate hypoxic conditions (5% O2 or
36 mmHg). Whereas it is well established that the culture of
mature SMCs leads to a decrease of contractile markers associated
with a pathological phenotype [20–22], we focused on SMCs-like
cells obtained under hypoxia conditions and we checked the
preservation of the contractile phenotype after further cell
expansion (effect of passage number) and culture even under
normoxic conditions.
These experiments demonstrate clearly the deterministic role of
the oxygen content in vascular progenitor cells differentiation into
mature functional cells constituting the vascular wall (media and
intima).
Methods
1) Polyelectrolyte Multilayer Films (PEMs)
PEMs were built with cationic poly (allylamine hydrochloride)
(PAH, MW=70 kDa), and anionic poly(sodium-4-styrene sulfo-
nate) (PSS, MW=70 kDa) solutions (Sigma-Aldrich, France) as
Figure 1. Morphological aspect of differentiated cell. Optical phase contrast microscopy visualization of differentiated cells seeded on type I
collagen (A, B) and polyelectrolyte multilayer films (PEMs) (C, D) until confluence under normoxic (A, C) and hypoxic (B, D) environment.
Objective620, scale bar 55 mm. The morphological examination of the confluent cells showed cobblestone shape (A, C) in normoxia and a spindle
like (B, D) shape in hypoxia.
doi:10.1371/journal.pone.0005514.g001
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glass coverslips (CML, Nemours, France) pretreated with 0.01 M
SDS and 0.12 M HCl for 15 min at 100uC and then extensively
rinsed with deionized water. Glass coverslips were deposited in 24-
well plates (Nunc, France). PAH-(PSS-PAH)3 films were obtained
by alternated immersion of the pretreated coverslips for 10 min in
polyelectrolyte solutions (300 mL) at 5 mg/mL in the presence of
10 mM Tris-(hydroxymethyl) aminoethane (Tris) and 150 mM
NaCl at pH 7.4. After each deposition, the coverslips were rinsed
three times during 10 min with 10 mM Tris and 150 mM NaCl at
pH 7.4. All the films were sterilized for 10 min by UV light
(254 nm).
2) Isolation and culture of Mononuclear Cells from
peripheral blood circulation
The experimental procedures were used in accordance with the
‘‘Principle of Laboratory Animal Care and the Guide for the Care
and Use of Laboratory Animals’’ (National Institute of Health
publication No. 80–23, revised 1978). Blood (50 mL) was collected
from white New Zealand rabbits (male, average weight 3–3.5 kg,
CEGAV, France) carotid into heparinised plastic syringes.
Peripheral Blood Mononuclear Cells (MNCs) were isolated using
a density gradient as previously described [19]. The cells were then
cultivated in endothelial basal medium (EBM-2: Lonza, Belgium)
supplemented with angiogenic growth factors (EGM-2-single-
Figure 2. Vascular cell phenotype characterization. The endothelial cell were characterized by the expression of specific markers: CD31 (A–D)
and von Willebrand Factor (E–H) and the smooth muscle cells by the expression of contractile markers: a- Smooth Muscle Actin (a-SMA: E–H), Smooth
Muscle Myosin Heavy Chain (SM-MHC: I–L) and Calponin (M–P). Images were obtained by confocal microscopy observation at cell confluence on both
coated surfaces (type I collagen and Polyelectrolyte Multilayer films (PEMs)) and cultivated under normoxic and hypoxic conditions. Objective640,
NA=0.8, scale bars 75 mm. The figure showed the positive expression of specific ECs markers for cell differentiated under normoxic environment and
positive expression of specific contractile SMCs markers for cell differentiated under hypoxic environment.
doi:10.1371/journal.pone.0005514.g002
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and were seeded at a density of 1610
6 cells/cm
2 in 24-well plates
containing glass coverslips coated either by Type I collagen 1%
(BD Biosciences, France) or a PEMs films, made of PSS and PAH
(Sigma, France) with a final PAH-(PSS-PAH)3 architecture
corresponding to 3.5 pairs of deposited PAH/PSS layers [19].
The cultures were placed in normal cell culture incubator at 37uC
in an atmosphere with 5% CO2 and 21% O2,( O 2/CO2
incubator, Sanyo, France). After three days, the medium was
removed in order to discard unattached cells. The cells (CD34
+,
CD133
+ were identified previously [19]) were then placed under
hypoxia at 37uC, 5% CO2 and 5% O2 or under normoxia at
37uC, 5% CO2 and 21% O2 (control) and medium changed every
two days. The differentiation and morphological evolution of the
adherent cells were followed by Phase-contrast microscopy
observations (Nikon DIAPHOT 300, Japan).
3) Immunostaining for smooth muscle cells (SMCs) and
endothelial cells (ECs) specific markers
At confluence and after the third passage, cells were also
immunolabelled against SMCs and ECs specific markers. Three
antibodies were used to characterize the contractile SMCs
phenotype: i) Alpha Smooth Muscle Actin (a-SMA), ii) Smooth
Muscle Myosin Heavy Chain (SM-MHC) and iii) Calponin. Two
other antibodies were used for the ECs phenotype: i)C D 3 1ii)v o n
Willebrand factor (vWF) (all from Dako, France). Prior to the
immunolabelling with the intracellular antibodies (a-SMA, SM-
MHC, Calponin and vWF), the cells were fixed with paraformalde-
hyde (PAF) 4% (w/v in phosphate buffer saline) for 10 min and
permeabilized with Triton X-100 0.5% (w/v in distilled water) for
15 min. For CD31 labelling the second step (permeabilization) was
not performed. The cells were incubated for 45 min at 37uCw i t ht h e
primary monoclonal antibodies, diluted at 1/50 in RPMI 1640
without phenol red, containing bovine serum albumin (BSA 0.5%,
w/v). After two washes with RPMI 1640, the secondary antibody
labelled with Alexa-FluorH 488 diluted at 1/100 was incubated for
30 min at 37uC. The cells were observed by fluorescence confocal
microscopy (LEICA DMIRE2 HC Fluo TCS 1-B, Germany) using
the 488 nm spectral line.
4) Immunostaining for extracellular matrix (ECM) proteins
At confluence, hypoxia differentiated cells were immunostained
for ECM proteins characterization via two specific proteins such as
i) laminin and ii) type IV collagen. The differentiated cells were
fixed with PAF 4% for 10 min and incubated for 45 min at 37uC
with the primary monoclonal antibodies, diluted at 1/50 in RPMI
1640 without phenol red, containing 0.5% BSA. After two washes
with RPMI 1640, the secondary antibody labelled with Alexa-
FluorH 488 diluted at 1/100 was incubated for 30 min at 37uC.
The cells were observed using fluorescence confocal microscopy
(LEICA DMIRE2 HC Fluo TCS 1-B, Germany).
5) Evaluation of the maintenance of the SMCs phenotype
In order to checkthat after a firststep of culture under hypoxia, the
differentiation into SMCs was stable versus time, cells were further
cultivated either under hypoxia or normoxia. After differentiation the
Figure 3. Extracellular matrix synthesis. The confocal microscopy observations of Extracellular matrix protein: laminin (A, B) and type IV collagen
(C, D) of cells seeded on both coated surfaces (type I collagen and Polyelectrolyte Multilayer films (PEMs)). Objective640, NA=0.8, scale bars 75 mm.
doi:10.1371/journal.pone.0005514.g003
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and separated in two batches. The first batch was kept under hypoxic
condition (37uC, 5% CO2 and 5% O2) whereas the second batch was
placed in normoxic conditions (37uC, 5% CO2 and 21% O2). Cells
were then cultivated in these different conditions until the third
passage (P3)and mature SMCs from rabbitaorta cultivated under the
same conditions were used as control.
6) Fluorescence Activated Cell Sorting (FACS)
FACS analyses (EPICS XL, Beckman Coulter, France) were
performed to quantify the percentage of positive cells and the
fluorescence intensity of the specific contractile markers expressed
by the differentiated SMCs. After P3, FACS was performed to
identify intracellular antigens in cells. For that, trypsinized
differentiated cells were labelled as previously described. The
non-specific binding was evaluated by the incubation of cells only
with the second antibody. Within the differentiated cell area, as
determined by forward and sideward scattering, 10,000 events
were collected and the percentage of positive cells and the mean
fluorescence intensity (MFI) were determined.
7) Statistics
The data were expressed as mean6standard error of the mean
(s.e.m.) for each condition. Each experiment was repeated in
triplicate independently three times. Mean values were compared
with the unpaired t-test (Statview IV, Abacus Concepts Inc,
Berkley, CA, USA), in which p represents the rejection level of the
null-hypothesis of equal means.
Results and Discussion
Peripheral blood mononuclear cells (MNCs) fraction containing
progenitor cells was isolated and seeded in 24-well plates
containing glass coverslips coated with type I collagen or with a
Polyelectrolyte Multilayer Film (PEMs) at 1610
6 cells/cm
2.W e
used type I collagen known as an ideal substrate for vascular
progenitor cells culture [2] and PEMs for their high potentialities
to boost progenitor cell differentiation [19]. After 4 days of culture
in normoxic conditions, unattached cells were removed and the
adherent cells (CD34
+, CD133
+) were divided in two fractions and
placed under hypoxia (5% CO2 and 5% O2) or normoxia (5%
CO2 and 21% O2) until confluence (between 2 and 4 weeks). At
confluence and for both surface types, the phase-contrast
microscopy cell observation showed cobblestone morphology in
normoxic conditions (Figure 1A, 1C) and a spindle like
morphology in hypoxic conditions (Figure 1B, 1D).
In order to evaluate the cell phenotype of differentiated cells, we
checked the expression of specific markers of vascular cells (SMCs
and ECs) i.e. alpha-Smooth Muscle Actin (a-SMA), Smooth
Muscle Myosin Heavy Chain (SM-MHC) and Calponin known to
assess vascular SMCs differentiation and their contractile function
[2,24,25] and CD31 and von Willebrand Factor (vWF) for the ECs
phenotype evaluation [26,27]. As expected under normoxic
conditions, the confocal microscopy observations showed the
presence of positive cells for ECs markers [Figure 2A and 2E (for
type I collagen coating), 2C and 2G (for PEMs coating)] and
negative cells for SMCs markers [Figure 2I, 2M and 2Q (for type I
collagen), 2K, 2O and 2S (for PEMs)]. Under hypoxia a surprising
positive expression of SMCs markers was observed [Figure 2J, 2N
and 2R (for type I collagen), 2L, 2P and 2T (for PEMs)]. No
expression of ECs markers was noticed under this condition
whatever the surface coating [Figure 2B and 2F (for Type I
collagen), Figure 2D and 2H (for PEMs)] indicating thus a total
absence of cellular differentiation into ECs at a low concentration
of O2. All these observations constitute a signature for the
progenitor cells switching into SMCs phenotype. These results
suggest first the potentiality of MNCs cells to differentiate into a
SMCs phenotype under a hypoxic environment and second the
expression of the specific markers confirmed the contractile
phenotype of these cells [28] (similar to SMCs in vivo). In the
literature the hematopoietic stem cells differentiation into mature
and functional SMCs requires the culture medium supplementa-
tion with specific growth factors, especially PDGF-BB [2,3]. Our
results demonstrate that the oxygen concentration tuning alone
allows phenotype switch either to endothelial cells or smooth
muscle cells.
The extracellular matrix (ECM) contributes to the control of the
cellular function and is involved in maintaining the cells in a
differentiated state [29,30]. During blood vessel formation the
SMCs are responsible for extracellular matrix formation via
protein (fibronectin, laminin, collagens…) secretion [31]. The
ECM deposition contributes in vivo and in vitro (tissue
engineering approach) to arterial wall constitution and cell
function via different signalling pathways (kinase pathways
activation) [31,32]. We investigated the capacity of the differen-
tiated cells under hypoxic conditions to synthesize their own ECM,
and we evaluated the secretion of two extracellular proteins
(Laminin and type IV collagen), which play a major role in ECM
synthesis and contribute to maintain the contractile phenotype of
the differentiated cells [31]. Confocal microscopy observations
showed the deposition of both of these proteins. The comparison
between both surfaces showed moreover a stronger synthesis of
ECM by the cells cultivated on PEMs (Figure 3). These data
obtained under hypoxic conditions confirmed the capacity of
MNCs to differentiate into SMCs, exhibiting a contractile
phenotype, sign of a correct physiological state and integrity of
the ECM. This integrity plays a key role to maintain this state and
suggests stability over longer time periods.
The phenotype stability over a longer time period of the SMCs
derived from MNCs cultivated under hypoxia is a major issue to
use this route in tissue engineering for example. The SMCs
phenotype stability was investigated at low or high oxygen
concentration. After the first passage of hypoxic differentiated
cells (cells positive to SMCs markers), the obtained cells were
expanded under two conditions. For the first assay we maintained
cells under hypoxic condition and for the second assay we placed
cells in normoxic condition. In order to check the stability of the
SMCs phenotype under these conditions, several passages (P3)
were performed. Whatever the experimental condition (hypoxic
Figure 4. Phenotype stability under hypoxia. After the third passage, the smooth muscle cells phenotype stability of differentiated cell
cultivated under hypoxic conditions was investigated by confocal microscopy observation (A) and flow cytometry analyses (B, C). A: Confocal
microscopic observations showed positive cells for contractile markers: a- Smooth Muscle Actin (a-SMA), Smooth Muscle Myosin Heavy Chain (SM-
MHC) and Calponin confluence on both coated surfaces (type I collagen and Polyelectrolyte Multilayer films (PEMs)). Objective640, NA=0.8, scale
bars 75 mm. B: Flow cytometry showed that more than 80% cells expressed SMCs markers. C: Mean fluorescence intensity analyses showed a higher
SMCs contractile markers expression for differentiated cells compared to control (mature SMCs) whatever the surface coating. (1)PEMs versus control,
(*) Collagen versus control, (#) PEMs versus collagen. (1,* and #: p,0.05 and 111 and ***: p,0.001).
doi:10.1371/journal.pone.0005514.g004
O2 Controls Progenitor Cells
PLoS ONE | www.plosone.org 6 May 2009 | Volume 4 | Issue 5 | e5514Figure 5. Phenotype stability under normoxia. After the third passage, the smooth muscle cells phenotype stability of differentiated cell
cultivated under normoxic conditions was investigated by confocal microscopy observation (A) and flow cytometry analyses (B, C). A: Microscopical
observations show positive cells for contractile markers: a- Smooth Muscle Actin (a-SMA), Smooth Muscle Myosin Heavy Chain (SM-MHC) and
O2 Controls Progenitor Cells
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not shown).
Under hypoxia the cell characterization showed the positive
staining for SMCs markers with a regular cytosolic distribution of
all observed SMCs markers (Figure 4A) for both coating types
(Type I collagen and PEMs). These data were correlated with
FACS analyses which indicated that, after the third passage, more
than 80% of cells were positive for both surfaces (Figure 4B). We
compared moreover the Mean Fluorescence Intensity (MFI) of
SMCs contractile markers expression of the differentiated cells
with mature SMCs extracted from rabbit aorta and cultivated in
the same medium in normoxic and hypoxic conditions. Mature
SMCs were cultivated on the usually employed tissue culture
plastic surface (TCPS) [33] showing no difference with a control
performed on type I collagen and PEMs. The expression of a-
SMA, SM-MHC and calponin for cells cultivated on both Type I
collagen and PEM coated surfaces was significatively higher for
the differentiated cells compared to mature SMCs, although less
important on the collagen coated surface for a-SMA.
Under normoxic conditions, the expanded cells were also
qualitatively and quantitatively characterized by confocal micros-
copy observations and by FACS analyses. As for hypoxic
conditions, the visualized cells were positive for SMCs contractile
markers with again a regular cytoplasmic distribution (Figure 5A).
FACS analyses showed also that more than 80% of differentiated
cells were positive to SMCs contractile markers (Figure 5B). The
MFI of contractile markers for differentiated cells was significa-
tively higher than for mature SMCs for both surfaces coating and
with no differences for differentiated cells cultivated on type I
collagen and PEMs coated surfaces (Figure 5C). It is also
important to state that no significatively difference was found in
the expression of the three contractile markers once comparing the
data obtained in hypoxic and normoxic conditions.
It is well known that in vitro mature SMCs extracted from vessels
switch their phenotype from a contractile (healthy) to a
proliferative (pathological) phenotype [34,35]. This switch consti-
tutes a strong limitation for blood vessel tissue engineering. The
present differentiation approach allowed us to obtain a ‘‘healthy’’
phenotype of SMCs which could constitute an alternative for
vascular tissue engineering. We observed effectively a quite
stronger expression of the contractile markers for the differentiated
cells compared to mature SMCs. In a different context (in
particular during vascular wall remodelling after bypass surgery) a
reduced tissue oxygenation together with the presence of
inflammatory cells could be at the origin of vascular wall
recolonization by SMCs, the origin of which was not elucidated
up to now [9,36–38].
To conclude we demonstrated that progenitor cells cultivated in
hypoxic conditions and without specific growth factor enhancing
SMCs differentiation displayed morphological and phenotypic
properties of SMCs as showed by the expression of SMCs
contractile markers. Moreover, these differentiated SMCs main-
tained their contractile phenotype when replaced in normoxic
conditions suggesting that these cells developed a stable and
functional phenotype comparable to physiological SMCs found in
functional blood vessels.
These results highlight the crucial role of the tissue environment
and especially the O2 content in the differentiation process of
vascular progenitor cells. These observations combined with
previous ones [19] could constitute a basis for tissue engineering
and clinical application strategies for in vitro tissue reconstruction.
For example in vascular tissue engineering, starting from an
unique peripherical blood sample cultivated on PEM and with the
same culture media, but in normoxic or in hypoxic conditions
either mature ECs (21% O2) or contractile SMCs (5% O2) can be
obtained in less than one month. The different layers (media and
intima) could be associated to build for example a natural a natural
and autologous vascular graft.
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